Breast Cancer Liquid Biopsy Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

By Offerings (Assay & Reagents Kits, Instruments), By Circulating Biomarker (Circulating Tumor DNA, Circulating Tumor Cell, Extracellular Vesicles), By Application (Cancer Applications, Non-Cancer Applications), By Region, and By Competition

Published	Pages	Publisher	Report code
Nov 2023	182	TechSci Research	ASDR-642587

Published: Nov 2023 - Pages : 182 - Publisher : TechSci Research - Report code : ASDR-642587

1. A Menarini AG
2. NeoGenomics Laboratories Inc
3. F Hoffmann-La Roche AG
4. Myriad Genetics Inc
5. QIAGEN NV
6. Biocept Inc
7. Sysmex Corp
8. Fluxion Biosciences Inc
9. Thermo Fisher Scientific Inc
10. Epic Sciences Inc

Breast Cancer Liquid Biopsy Testing Devices - Global Forecast 2024-2030

This report can be of interest as well:

Breast Cancer Liquid Biopsy Testing Devices - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-645656

Mark your calendar:

Oligonucleotide Therapeutics and Delivery Conference 2024

09 September - 10 September, 2024
London, United Kingdom